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INTRODUCTION AND HISTORICAL REVIEW 
"Has the point been reached where the enormous use of 
antibiotics is producing as much harm as go6d? Are the 
risks beginning to outweigh the benefits?" (Simmone 
and Stolley, 1974). 
On December 7, 1972, a hearing was held in Washington, 
D. C. on the use and abuse of antimicrobials. Senator 
Gaylord Nelson of the Sub-committee on Monopoly of the 
Select Committee on Small Business stated, "Antibiotics are 
among the most frequently prescribed drugs in this country, 
exceeded only by the psychoactive drugs." Dr. Charles C. 
Edwards, former Commissioner of the Food and Drug Adminis-
tration, recognized that a problem existed and recommended 
the establishment of a National Task Force on the clinical 
use of antimicrobials (Kunin, et al., 1973). 
The following examples illustrate problems the medical 
profession faces with antimicrobials. 
Of the 33 million patients discharged from general 
hospitals in 1972, 27% received one or more antibiotics dur-
ing their hospital stay. This totals almost 9 million 
patients receiving antibiotics during the course of the 
year (McGowan, 1976). 
1 
2 
Firikel (1978), explained that the amount of injectable 
cephalosporins certified by the FDA increased from approxi-
mately 25 million doses in 1974 to approximately 40 million 
in 1977. 
Antibiotic usage had increased 300% between 1960 and 
1970, whereas the population increased only 11% (McGowan, 
1976). In 1962 approximately 94 million dollars worth of 
antibiotics were purchased by hospitals; in 1971 approxi-
mately $218 million dollars were spent (Simmone and Stolley, 
1974). 
Kass (1978), states, "because prophylaxis for all sur-
gical procedures accounted for about 30% of all antibiotic 
drug use, discontinuing prophylaxis 48 hours after the pro-
cedure would save about 20% of all antibiotic drugs used 
in hospitals. Translated into an annual figure for the 
country, the prospective saving would be approximately 
$100 million or more." 
Dr. Mark Novitch, Acting Associate Commissioner for the 
FDA (1979), stated (Antibiotic Audit, 1979), "With anti-
biotic drug spending running close to a billion dollars a 
year, the importance of using lower cost drugs that will 
yield the same results cannot be overstated." 
Scheckler and Bennet (1970), in conjunction with the 
Center for Disease Control (CDC), in Atlanta, Georgia, con-
ducted a study from November 1967 to June 1969. Thcyre-
viewed the medical records of 5,256 patients to evaluate 
------ ---- --------- ------
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antibiotic usage. Results showed that 62% of the patients 
had no definite evidence of infection. 
Another retrospective review, involving cephalosporin 
usage, in a 1200-bed university hospital revealed that 
52% of the cephalosporins prescribed were classified in-
appropriate by the standards of infectious disease clinicians 
(Counts, 1977). 
Locally, Dr. George Herron, a physician and assistant 
professor of clinical pharmacy, School of Pharmacy, Univer-
sity of the Pacific (UOP), Stockton, California conducted 
an antibiotic study at the San Joaquin General Hospital dur-
ing 1974, (Personal Communication). One hundred and one 
cases were reviewed, 45.5% were found inappropriate. I nap-
propriate usage included prescription of an antibiotic 
other than the drug of choice, or use of an antibiotic in 
the absence of culture and sensitivity tests. Inappropriate 
prophylaxis in surgery was also found. There was a trend 
in the misuse and overuse of the broader spectrum drugs, 
especially the cephalosporins. Dr. Herron and his pharmacy 
students speculated that if the trend ~ontinues, emergence 
of resistant bacterial strains and superinfections may 
occur. 
"Danger in misuse of antibiotics becomes apparent," ac-
cording to Simmone and Stolley (1974), when "Hundreds of 
thousands of patients may be unnecessarily exposed to the 




to antibiotics such as a rash, toxic reaction, morbidity 
associated with administration, such as chloromycetin associ-
ated blood dyscrasias, and anaphylactic shock in about 5% 
of hopsitalized patients~ Misuse also adds to the rising 
cost of medical care .. 
Considerable variability in antibiotic usage probably 
occurs in different hospitals. It is possible that a larger 
number of resistant organisms are associated with the 
nosocomial infections in hospitals with greater antibiotic 
usage although no definite correlation between usage and 
prevelance of nosocomial infections has been established 
(Scheckler and Bennett, 1970). 
McGowan and Finland (1974) suggested that the major 
factor responsible for the changing ecology of bacterial 
flora to Gram negative bacteria and for the marked increase 
in their occurrence, at least at Boston City Hospital, is 
the selective pressure of the widely and intensively used 
antibiotics in therapy and prophylaxis. Finland also be-
lieves the overuse of antibiotics may lead to predisposi-
tion to infection and selection for superinfections. In 
1967, approximately 250,000 Gram negative bacteremias ocur-
red in American hospitals contributing to at least 50,000 
-
deaths (Simmone and Stolley, 1974). 
The preceding problems and studies illustrate the need 
and justify the regulations for monitoring antibiotics 
imposed by the Joint Comfuission on Accreditation of Hospitals 
(JCAH). The 1976 statement by the JCAH stated, "One of the 
5 
basic elements of an effective hospital infection control 
program involves coordination with the medical staff on 
action relative to the findings from the regular review 
of the clinical use of antibiotics. The continuous mon-
itoring of antibiotic usage in the hospital is a medical 
staff responsibility" (Porterfield, 1976). 
Dr. John Porterfield of JCAH recognized the Pharmacy-
Therapeutics and Infection Control Committees as the formal 
organizational elements with the ultimate responsibility 
for formulating drug usage studies and overall administra-
tion of a quality assurance program. It was the opinion 
of Zeman et al., (1974), that in a large hospital (more than 
500 beds) a separate Antibiotic Utilization Committee may 
more efficiently handle the volume of data and work. 
To implement this monitoring system, Brodie and Smith, 
(1976), recommended five drug utilization review principles: 
{1) authority, (2) operational and demographic character-
istics of the delivery setting and service population, (3) 
knowledge of the existing pattern of utilization, (4) com-
parison of the later with local standards, and (5) evalua-
tion of the impact of review on utilization patterns. 
Pierpaoli, et al., (1976), suggested that, conceptually, 
a monitoring program could include utilization of retro-
spective and prospective ch~rt review processes, compli-
mented by a formal educational program, and in-house controls 
on the use of certain antibiotics. 
--------------------------------------- -------------------- -- ------- ------ ----------
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A monitoring system could consist of evaluating anti-
biotics in three possible ways: (1) evaluate the usage of 
an antibiotic, or a family of antibiotics, in all medical-
surgical cases, (2) evaluate one type of medical or sur-
gical problem and review prophylactic and therapeutic use 
of all antibiotics, or (3) evaluate the usage of one anti-
biotic in one type of medical or surgical problem. 
The third method of studying one antibiotic in one type 
E 
' 
of clinical condition mi ht have some advantage__..s,____,s"-'1""'-'. n'-'-"'-c..,_e_____.,t-"'h.__,e,____ ____ ~ 
number of variables is much smaller than either of the 
other two systems. I decided to use this approach and con-
centrate on open-heart surgery in which the cephalosporins 
have been used prophylactically. 
St. Joseph's Hospital was among the first hospitals 
in California to initiate a monitoring program. The pres-
ent investigator was the Infection Control Nurse at the 
time and played a major role in devising the methods and 
procedures to be used in such an endeavor at the local 
and state levels. 
Since 1977, data from the surveillance records (Ap-
pendix 1) has been tabulated on a monthly basis by the Pharm-
acy staff at St. Joseph's Hospital. A monthly report (Ap-
pendix 2) is presented to the Infection Control and Pharmacy-
Therapeutics Committees. Problem areas are discussed and 
recommendations are forwarded to other medical committees, 
or further studies are initiated. 
---=--=-=-=====-=-===-=-====-=----------------
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From the monthly reports of 1978 three problems were 
defined: (1) excessive usage of the Cephalosporins~ (2) 
questionable prophylactic use of antibiotics, including 
duration of therapy, (3) questionable dosing and lack of 
adequate laboratory monitoring of serum levels of amino-
glycosides. 
Currently at St. Joseph's Hospital, the Pharmacy staff 
is concentrating its monitoring efforts ori the utilization 
11-------,a-f--a-m-i-n--e-g-l_...y--eLJ-s-i-d-e-a-n-t-l~b-i-e-t-i-e-s-i-n-a-l-l-m-e-cl-i-e-a-l-a-n-cl-s-tl-r-g-i-e-a-ll-------~ 
patients (Appendix 3). 
I selected the use of Cephal6sporins in open-heart 
surgery for this retrospective review for the following 
reasons: (1) only three Cephalosporins (Cephalexin, KeflexR; 
Cefazolin, AncefR; Cephalothin,KeflinR) are used prophylac-
tically, (2) only four open-heart surgeons are involved, and 
(3) standing orders relating to use and administration of 
Cephalosporins are generally uniform or vary little from 
one surgeon to another. 
R = Registered Trademark (Brand Name) 
KeflexR and KeflinR - Eli Lilly and Company, Indiannapolis, 
IN. R 
Ancef - Smith Kline Laboratories, Philadelphia, PA. 
---=---=---=--=-=-=========-=-=-=-==-=-=--=-=----- -------------------- - ---- ------------------------
MATERIALS AND METHODS 
The site of this investigation was St. Joseph's Hospital, 
a 316-bed, acute-care, non-profit institution in Stockton, 
California. 
open-heart surgery from September through November 1978 were 
obtained from the Medical Records Department and were evalu-
ated for pre- and post-operative prophylactic use of anti-
biotics and any post-operative infections. A check-list 
monitoring form (Appendix 4), similar to that used for the 
monthly antibiotic utilization review (Appendix 1), was 
devised and used to audit records of these open-heart sur-
gery patients. 
For each of the 33 patients the dates of admission to 
the hospital, surgery and discharge from the hospital were 
recorded. The medication record of each patient relating 
to the antibiotic dose, route of administration, dose inter-
val and therapy duration (start and stop dates) was also 
documented. Patient parameters such as daily temperatures 
(Celcius), total white blood count (WBC), differential with 
emphasis on segmented and band cells (neutrophils), chest 
x-rays, and specimen culture data (site, organisms, suscepti-





the clinical signs and symptoms to determine any post-
operative nosocomial infections. 
Antibiotic therapy was then evaluated using five 
categories: (1) rationale for use, (2) route of adminis-
tration, (3) dose, (4) duration of pre-operative prophylaxis, 
and (5) duration of post-operative prophylaxis. According 
to Prian and Nelson (1978), criteria for prophylactic 
therapy is defined as: "Depending upon the individual situa-
tion, the antibiotic chosen will be prophylactic or thera-
peutic and may be specific or general in its coverage. When 
used in the non-infected patient undergoing a clean opera-
tion, the use of antibiotics is termed prophylactic". The 
prophylactic use of antibiotics was judged as appropriate 
or questionable by criteria established in The Medical 
Letter on Drugs and Therapeutics (1977). 
1. Rationale: The current literature on this 
topic indicates the prophylactic use of anti-
biotics in open-heart surgery is justified even 
though a Class I wound is considered clean and 
does not justify prophylaxis. A Class I wound 
is defined as "clean" when the respiratory or 
gastro-intestinal tract is not surgically en-
tered (Actemeier, 1976). 
2. Route of administration: Ancef and Keflin are 
given intravenously or intramuscularly, and 
Keflex orally. 
3. Dosage: Ancef is usually gtven 0.500 to l.OOOg, 
every 8 hours; Keflin lg every 4-6 hours and 
Keflex 0.250-0.500g every 6 hours, but not to 
exceed 4g in 24 hours. 
4. Duration of pre-operative prophylaxis: "Anti-
microbials should generally be given one to 
two hours before surgery, which is enough time 
to achieve therapeutic drug levels in the wound 
during the operation, but not enough time to 
----
select bacteria resistant to the drugs." The 
time duration criteria for this audit was ex-
panded to twenty-four hours to allow for late 




5. Duration of post-operative prophylaxis: Twenty-
four hours of post-operative prophylaxis is con-
sidered appropriate therapy. Forty-eight hours 
was considered appropriate for this review. 
Post-operative infections: Complications such as infec-
tions of the surgical wound, urinary tract, respiratory tract, 
septicimia, and infectious endocarditis sometimes result 
after surgery. The CDC, for example, estimates that approxi-
mat~ly_5J,_of _hospitalized patients will develop "nosocomial" 
infections. The "nosocomial" infections are defined by CDC 
as "infections which express themselves in hospitalized 
patients in whom the infection was not present or incubating 
at the time of admission" and include "infections which are 
potentially preventable as well as some that may be regarded 
as inevitable''. Since the aim of prophylactic use of anti-
biotics in open-heart surgery is to prevent, as far as pos-
sible, complications of infections, the records of the 33 
patients under study were audited for post-surgical infec-
tions to determine efficacy of prophylaxis. The records 
were audited using the following criteria to judge post-
operative infectious complications. 
1. Surgical wounds: A surgical wound draining 
purulent material, the culture may or may not 
be positive. 
2. Urinary tract: A colony count on a clean catch 
or urinary catheter sample exceeding 100,000 
bacteria/mi. 
11 
3. Post-operative respiratory infections: Purufent 
sputum, a chest x-ray showing infiltrates or 
other positive signs, and/or a positive sputum 
culture. 
4. Post-oper~e septicemia: Presence of bacteria 
in the blood with clinical signs of infection 
(Bryan, ·1978). 
5. Post-operative infectious endocarditis: Bacteremia, 
fever, splenomegaly, embolic manifestations, new 
heart murmur, or a positive culture from the valve 
or heart. Infectious bacterial endocarditis is 
diagnosed if the patient demonstr~tes three of 
*--------------+.._ h-e----s-:t-.h-1-i-s-t-ed-c-r-i-t-er-i-a•-.---------------------~ 
The above definitions are for infections only; "Coloniza-
tion implies the presence of a microorganism in or on a host 
with growth and multiplication of the microorganism, but 
without any overt clinical expression or detected immune 
reaction at the time it is isolated" (Bennett and Brach-
man, 1979). 
The statistical test used in this study was a one-tail 
independent t-test on the difference of mean time of post-
operative prophylactic antibiotic therapy between the infec-
ted and non-infected population groups. Additionally, a 
test was run on the difference of the infection rates for 
the two groups. 
;;==========--=-=-==-====~=--=--==---~-- --- ~- ------- -----------------------
RESULTS 
Review bf thirty-three medical records for open-heart 
surgery showed evidence of the following (Table I): Patient 
data are statistically displayed by the mean with the range 
included in parenthesis. If a percentage is used the numera-
tor and denominator are included in the parenthesis. 
Length of stay: The mean length of stay in the hospital 
for an opert-heart surgery patient was 17 days, (9-39d). 
Patient data: The mean baseline clinical data for the 
32 patients (one patient expired during the operation) and 
the ranges (in parenthesis) were: Temperature 37C (35.8-
39.6); WBC 10,321 (1500-25,900); Segmented cells 66 (27-97); 
and Band cells 7 (0-57). 
Chest x-ray: Thirty-two patients in the study had a pre-
and post-operative chest x-ray. Eig9ty~four percent (27/32) 
of the patients were admitted with a normal chest x-ray, 
21 of those 27 developed post-operative abnormalities within 
a mean of 38 hours (0-7d). Sixteen percent of the patients 
(5/32) were admitted with abnormal chest x-rays, 3 of those 
5 developed further chest x-ray abnormalities post-surgery. 
Differences in infection rates were not significantly dif-







Infections: According to the criteria described in 
Materials and Methods, 25% (8/32) of the patients developed 
nosocomial infections at multiple sites: 22% (7/32) wound, 
3% (l/32) urinary, and 9% (3/32) respiratory. None of the 
patients developed septicemia or infectious endocarditis. 
Culture reports: Analysis of the cultures showed the 
frequency of occurrence for bacteria as follows: 
Wound: Twenty-two percent (7/32) of the patients had wound 
cultures taken. Two of the seven were positive; one had Staph. 
epidermidis and the other patient a mixed culture of entero-
cocci, Proteus mirabi1is and Staph. aureus. 
Urine: Forty-four percent (14/32) -of the patients had 
urine cultures taken of which two were positive. E. coli 
was found in both patients; one patient had a community-
acquired infection and the other patient a nosocomial 
urinary tract infection evident by pre-operative urine 
cultures. 
Sputum: Thirty-four percent (11/32) of the patients had 
sputum cultures taken of which seven were positive. Thir-
teen percent (4/32) of the patients were con$idered to 
have a colonization whereas 9% (3/32) of the patients were 
documented as having nosocomial respiratory infections. 
Organisms recovered from the colonized patients were Beta 
hemolytic streptococci, non-group A (1/4), Citrobacter 
diversus (1/4), Enterobacter aerogenes (1/4), Enterobacter 
cloacae (1/4), and Pseudomonas aeuroginosa (1/4). The 
;;===========-=-=-======--=--=.::---==--=:~.=-:----------- --------------- -- --- ------- --- -- ----------------------
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seven positive cultures of the remaining three patients with 
respiratory infections showed the following organisms: 
Enterobacter aerogenes (2/7), ~· coli (1/7), Klebsiella 
pneumoniae (1/7), Pro1~ mirabilis (1/7), !:· morganii (2/7), 
and Pseudomonas fluo:tE~scens (1/7). Every patient had more 
than one organism in his/her sputum. 
Blood: Thirteen percent (4/32) of the patients had 
blood cultures taken and all were reported to have no growth. 
actic therapy to incidence of patients acquiring nosocomial 
infections indicated the following: (Table II) 
Days of post-operative 
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The mean duration of antibiotic therapy post-operative 
was 7.42 days (l-13d). The mean duration for administration 
of 1 gm Cefazolin IVPB every 8h was 58 hours (l-12d) and 
oral Keflex 500mg every 6h was 5 days (0-13d). The above 
data show that only one patient (3%, 1/32), met the criteria 
for 48 hours maximum duration of post-operative prophylaxis 
coverage. 
Eighty-five percent (28/33) of the patients met the 
criterion of 24 hours pre-operative prophylaxis. Five patients 
aid not meet the criterion: (1) 2 doses, 2 days prior to 
surgery; meaning no prophylaxis within 24 hours prior to 
surgery, with no documented reason, (2) 3 days duration with 
no documented reason, (3) 8 days of pre-operative prophylaxis 
due to anticipated pulmonary problems, (4) 16 days pre-
operative prophylaxis for anticipated pulmonary problems, 
and (5) one pati~nt was excluded from the criteria because 
of expiration during surgery. 
The rationale of therapy, route of administration, and 
drug amount dosage for all patients were 100% appropriate 
for the criteria selected. 
Complications: (Table II) The total post-operative 
complication rate was 91% (30/33): 25% (8/32) of the patients 
developed a nosocomial infection, 75% (24/32) chest x-ray 
complications, and 9% (3/33) miscellaneous complications, 







The Center for Disease Control (CDC), in Atlanta; 
Georgia, has developed national standards for the diagnosis 
of nosocomial infections. Diagnostic tests and signs and 
Since some of the CDC's criteria are usually masked in 
open-heart surgery patients, modified criteria were used 
in this study. Masking of signs and symptoms is demon-
strated as follows: the mean temperature of 37C and the 
mean WBC of 10,321 were within normal limits; yet a 24% 
(8/33) infection rate existed for these patients. In ~-
5_ 
order to objectively determine infection, the criteria 
were based on positive microbiological laboratory findings; 
for example, a urinary tract infection is indicated by a 
colony count on a clean catch or urinary catheter sample 
exceeding 100,000 bacteriajml. 
Criteria for evaluating ~he use of prophylactic anti-
biotics were a modification of those suggested criteria from 
The Medical Letter on Drugs and Therapeutics, (1977). The 
criterion for the pre- and post-operative prophyla~is were 
modified to meet the needs of open-heart surgery patients, 
for example, The Medical Letter, (1977), states, ''anti-
microbial drugs can prevent wound infection and bacteremia 
16 
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in selected surgical patients, but not without risk. Po-
tential harmful effects include toxic or allergic reaction, 
bacterial or fungal superinfection, and altering the 
hospital environment in favor of bacterial strains resis-
tant to antibiotics." The Medical Letter (1977), further 
states, "antimicrobials should generally first be given 
one to two hours before surgery, which is enough time to 
achieve therapeutic drug levels in the wound during the 
j}---------~--p-e-r-a-t- i--O-n---,-----b-u-t-:tl-G-~!l-'-)-Y-g-ll-t-i-m-S-t-G---s-e-l-e-G-t-9-a-s-t-e-!!-i-a-F-e-s-i--S ~-----=-~ 
tant to the drugs." However, in this investigation 24 
hour pre-operative prophylactic criterion was used in 
order to allow for any emergency surgeries, late admissions 
or any possible error or deletion in medications. I be-
lieve results from this study and further investigations 
may yield data which may indicate further limiting of pre-
operative prophylactic antibiotic exposure. 
For post-operative prophylaxis The Medical Letter (1977), 
states "prophylactic drugs should be stopped within 24 
hours since continuing prophylaxis increases the risk of 
drug toxicity or bacterial superinfection and does not 
reduce the incidence of subsequent infection." Centro-
versy exists in the literature as to 24 or 48 hours being 
the limit for post-operative prophylaxis. The criteria 
were expanded in this study to 48 hours to allow for the 
majority of catheters such as intravenous, urinary, cen-
tral venous pressure and endo-tracheal, to be removed 
from the patient. 
~~~~~~========= --------- --H ---- -- - - ~-- - _-_-_- ----------
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Data obtained using these criteria are summarized in 
Table I, and show evidence of the following. Twenty-five 
percent (8/32) of the patients showed incidence of nosocomial 
infections. The CDC estimates that 5% of all hospitalized 
patients will develop nosocomial infections (CDC, 1974). 
The American College of Surgeons estimates a less than 1% 
wound infection rate for a Class I wound. This investiga-
tion shows evidence of a 22% (7/32) wound infection rate 
which exceeds all documented ranges and is statistically 
significantly higher than the national standard and there-
fore presents a serious problem. 
The nosocomial respiratory infection rate of 9% (3/32) 
coupled with a post-operative chest x-ray complication 
rate of 75% (24/32) is also an area of concern. This prob-
lem was not anticipated and needs to be further investi-
gated. 
The antibiotic criteria revealed a critical problem 
in the area of post-operative prophylaxis with only 3% (1/ 
32) of the patients meeting the 48 hour criteria. As in-
dicated in the Introduction, two of the several problems 
associated with overuse of antibiotics are superinfections 
and increase in the incidence of Gram-negative infection, 
both of which are evident in this investigation. 
It is evident from the above discussion that a dif-
ference exists in number of days post-operative prophylaxis 
between the infected and non-infected patient groups. A 
one-tail independent t-test on difference of means was run. 
---------- -- ------------------- ------------- ------ -----~--
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The results are significant at the .06 level but hot at the 
.05 level, Figure I and Figure II. Additionally, a test 
was run on the difference of the infection rates for the 
two groups. Patients receiving post-operative prophylactic 
antibiotics for eight days or less have a 15% nosocomial 
infection rate. Those patients receiving post~operative 
prophylactic antibiotics for greater than eight days have 
a 42% nosocomial infection rate. The results are significant 
the .05 level for the one-tail test. 
On the basis of this study the following recommendations 
are presented: 
1. Implement a prospective antibiotic monitoring pro-
gram for open-heart surgery patients which adheres to the 
criteria selected for this study. Appropriate statistical 
analysis could then be documented and hopefully infections, 
medical costs, and hospital length of stay would be reduced. 
2. Ihvestigate the time and duration of pre-operative 
antibiotic dosing for open-heart surgery patients and deter-
mine its effect on post-operative nosocomial infection. 
3. Investigate further the high incidence of post-
operative chest x-ray complications and nosocomial respira-
tory tract infections. 
4. Standarize post-operative wound care; currently 
policies and procedures do not exist in this hospital. 
5. Require cultures; 9% (3/32) of the patients did not 
have cultures taken when it was appropriate to do so. 
SUMMARY 
Medical records of 33 consecutive open-heart surgery 
patients were evaluated using selected criteria. The total 




32 ) of the at i en t s de~v e 1 oped a_n_o_s_QC_Qmi_al___in_f_e_c_tion_,_'Z_5_9f,___ _____ ~ 
(24/32) chest x-ray complications and 9% (3/33) miscel-
laneous complications, such as hepatitis, myocardial 
infarction, or intra-operative death. The study shows that 
there is a difference in number of days post-operative 
prophylaxis between the infected and non-infected patient 
groups at the .06 level of significance. 
Based on this investigation, the following recommenda-
tions were presented: 
1. Implement a propsective antibiotic monitoring pro-
gram for open-heart surgery patients which adheres to the 
criteria selected for this study. 
2. Investigate the time and duration of pre-operative 
antibiotic dosing for open-heart surgery patients and deter-
mine its effect on post-operative nosocomial infection. 
3. Investigate the high incidence of post-operative 
chest x-ray complications and nosocomial respiratory tract 
infections. 
4. Standardize post-operative wound care. 
5. Require cultures. 
20 
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Table I 
SUMMARY OF MEDICAL RECORDS FOR OPEN-HEART SURGERY 
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$-I ctt Q) > > > J..l ! ..... 
- ~J > ..-1 1-f <r-1 0 C1.l 
u:. UJ ~CJ ~(J ~CJ ~ U Cf.l I I,. 
C: Q ~ (lj "r'' ~ 'T"i $-4..-1 :J "0 M 
oeoo j...o.u w.u aJ+J ~ w M 
~ ~.:: ~.~ I g-.s g-~ ~ ~ ~ ~ ~ ~ ~ I I • 
tt;..: .u o ..c 1 ..c 1 1 .o aJ cu (jJ m £',.. QJ ~ cu _ ~ ~" . 11 Post-Operat1ve 
...-!UOO J"!"'i ~..-1 .u..-. P.!-.10!1 J..l......, ....,bQ ...,,..,..,. 
E " c a; '"' "' '"' ·"' '"' E "' c '-' a> c lih ., c:: c:: a> c:: Chest X-Rays Cultures Complications 
~Q~ ct~ ~~ ~~ ~~~ ~~~ ~~~ ~~~ 
8-25-78 I 24 h 48 h 3d I 36.8 14,742 67 5 8-25 & 8-29, clear; 9-21, L. thigh I Readmitted 9-18, debridement L. 
8-29-78 36.2- 780D- 53-90 1-12 8-31, R. base discoid Staph. ~. Proteu~: thigh acute cellulitis, gaping 
9-6-78 I 37.4 23,500 atelectasis; 9-1, mirabilis, Enterococc:( wound with drainage. 9/3 chest 
12 pleural effusion L.L:., I incision open & draining. 48h 
base post-op atelectasis R. base • 
• 
9-4-78 1 24 h 48 h 5 d 37 70 3 9-6, infil. L. lung; 9-12 sputum, normal Bhrpost-op atelectasis 
9-6-78 
1 
36-38.~ 8855 57-85 1-6 9-7, infil. R. base; flora 
9-15-78 5500- 9-8, 9, 11, 15, atel. 
11 13,100 R. & middle lobes & 
! R. base 
\ 
9-4-78 . 24 h 48 h 10 d 37 15,750 68 16 9-12,14,15, clear 9··21 urine 10
3 II 4 d post-op infiltrative changes 
9-12-78 36-38.6 4100- 51-91 1-41 9-16, CHF & infiltrates Pseudomonas and congestive heart failure 
9-26-78 23,100 9-17, atelectic R. base 
22 
. •. 
9-5-78 24 h 48 h 6 d 37 9227 65 4 9/7-14, pleural' fluid ------ I I abnormal chest x-ray from time of 
9-7-78 37-37 5700- 36-81 0-10 effus'ions admission and post-op. No fur-
9-16-78 14,900 ther complications. 
11 . / 
9-5-78 24 h 48 h 5 d 37 13,850 56 10 normal chest x-ray ------ 1 1 ----
9-7-78 37- 930D- 44-82 1-35 during hospitalization 
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·rrT· ~tilli,Li J!JUL 
Chest X-Rays 
9/6-13, clear 
9/14-17, bilateral pleural 
effusion 
9/19, atelectasis L. base 
9/21, resolving 1 
Cultures 
9/9-11, normal ~xr I 9/13 blood, no growth 
9/12, infH. or atel.L.L.L.• 9/14 sputum, normal 
9/13, bil. pleural eff. I flo~a 
9/16, atel. L. base , · 
9/18, bil. pleural eff. / 
9/19 & 22, infil. & atel. 1 
L.L.L. I 
9/10, 12, 13, 14, clear 
9/15, 16, 17, 19, 21, 24 
atelectic changes in bases 
1 9/18 sputum, normal 
· flora w/Staph. 
~ 
9/15,19,20,21,22, clear I 9/22 R. mediastial tube; 
9/24,25,26, pleural eff. ·1 Staph. epidermidis 
9/27, a tel. or infil. L.L.,l0/16 chest incision; 
base; 9/28, clearing; I Staph. epidermidis 
9/29, fluid in pleutal 10/21 sternal wound; 




basal pleural effusions 
10/1, clearing 






48 h post-op pleural effusion 
with further atelectasis L. 
base. 
24 h post-op infiltrate or.infil. 
L.L.L. 48 h post-op bilateral 
pleural effusions 
48 h post-op atelectasis in 
bases 
readmitted 10/16 sternotomy 
wound infection; 5 d post-op 
pleural effusion 
4 d post-op pleural effusion 
sputum culture is colonization 
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... 0 "'0 "' 0 ...... ,.. .... ,.. .... ,..., "' .. '" .. "'0 0.0 0.0 
"'"'"' 0 .... o..-< 0.0 1..0 I .0 I..-< ...... ....... '" .. " ... " ... ... "' 0 "' 0 "' O..< o..< O..< 
24 h 48 h 4 d 
Ancef; ~eflex 
I 48 h 1 d 
Naf. Clox. 
I 24 h I 96 h 110 d 
I 
I 






48 h 48 h 6 d 
'" ,., 
" .. 
"' '" ~ ,.. "" 















137 6- 460 ,_ 
37.8 11,100 
I rJJ I :!~r;w1J:: Ulr:hrmn:IU:J-;- 1: L lL ·r~ ~ ·1··;: r r .~,,[j[,kd ,[j~gt, i 
I I I I 
., ,... ,... 
'" u rn ., .... 
'" ..... .. '" ., '" Post-Operative "' "" UOD '" "' '" "' '" Complications " ... 00 "C.J-1 e.o Chest X-Rays Cultures OOGlC: "' '" "' c%~~ "' > "' o:><<>:: 
62 6 9/25,26,27,28, clear 9/27 urine, no growth 1 nosocomial wound infection 
47-83 0-18 9/29, L. base atelectasis (culture not taken of of chest incision ";. f' 
9/20,10/1,2,3,4, atel. or chest incision) atelectasis on day of operation 
infil. L. base 7 d post-op basal effusion 
10/6 L. basal effusion 
69 7 9/26 normal cxr 10/1 urine no growth · 
I 
1 nosocomial respiratory infec-
57-77 1-17 9/24,30,10/1,2, •infil. 10/2 sputum tion 24 h post-op infiltrate L. 
L.base; 10/3 density R. Pseudomonas fluorescens base. 
mid lung; 10/6 bil. basal Enterobaeter aerogenes . 
effusion & L.L.L. 
atelectasis 
.68 12 10/29, 10/2-4, clear 10/10 sputum Proteus 1 nosocomial chest tube site 
52-83 4-32 10/5 L. base atel. or morganii, Proteus wound infection; 1 nosocomial 
infil.; 10/6 atel. L. mirabilis 4 respiratory infection. U.L.: 10/7,9, bil. atel.; 10/11 urine 10 mixed (Chest tube site draining copious 
10/10 resolving; 10/16 flora with Pseudomonas yellow-drainage, foul smelling) 
basal atel. or effus. 10/10 CT site no growth 3 d post-op atelectasis 
10/18-21, R. pleural eff. 10/18 sputum normal flor~ 
10/23 R. pleural fluid; 10/18 sputum ~
10/24, atel. R. base; morganii, ~ 
10/26,29 atel. clearing mirabilis, Klebsiella . pneumoniae; 10/19 pleura~ 
I 
fluid no growth I 
63 15 10/2 normal cxr -----
I 
atelectic changes L. bases on 
50-75 8-26 10/5,6, atelectic changes day of surgery 
L. base; 10/i, 9, 11, 14, 
/ 
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192h 72h 
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24 h I 48 h 9 d 
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10/4 chronie ob~tructivQ 
lung disease?; 10/10 
normal cxr; 10/11-13 
atel. L. base; 10/14, 16, 
18, bilateral atelectasis 
10/6,10,16,17, normal 
18/18 effusion L. base 
10/21 infil. or pleural 
reaction L. base 
10/6,9, normal cxr 
10/10, discoid atel. R. base 
10/11, basal hazy densities 
10/12, 14, bil. pleural 
fluid; 10/16, 18,19,20, 
atel. & e£f. both bases 
10/18,20,21, normal; 
10/22,23,25,27,29, fluid 
in L; base; 10/31, 11/3, 
6,9, normal cxr 
\ 
Cultures 
10/19 graft no growth 
10/iO urine no srowth 
10/6 urine no growth 
10/17 urine E. coli 
10/23 urine no growth 
Post-Operative 
Complications 
1 nosocomial wound infection-
lower leg per discharge sum-
mary. 4 d post-op atelectasis 
L.L.L. 
atelec:Aais L. base on day of 
surgery 
48 h post-op L. base effusion 
24 h post-op discoid atelectasis 
R. base; 72 h post-op pleural 
fluid bilaterally 
1 nosocomial leg·wound infection 
readmitted 11/27 
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Table 1. Continued. 
1.{) 
;, .. .. 
C'\1 '" 00 "' .... '" ' .. >. ~g: '" "' .... " "' '" :> .. .... "' ... :> ........ -.-<0 '" "' .... ... ... "' '-'
! 
... <J 
"' <J "' <J .. UJ C<:l"-' ., .... ...... .. .... " ., H o ec o ..... "' ... '"'"' ... "' .... .... .. <:> 0 Q.O P.O "''" '" ... "' "'"' 
! 
.:Cr;1..::: 0.-< 0-.-1 o-< .. 00 '"' c 00 '-' 00 '"""' ... 0.0 1.0 1.0 "'"'"' ,, "' "' "' "' "' "' ·.·· .... <J 00 ..... ....... ....... - 00 ~~.. 0.0 &i,~gf ., .... 00 Post-Operative E a:l : '" ... "'" ... '"'"' " "' c u c'l> ~ c '" c "'0-Mc.J .... c 0 c 0 c "' :> "' § ~( ~ '" :> "' "' :> " Chest X-Rays Cultures Complications <:O..J I o..< O..< o..< H<<>:: <Zl<<>:: o:><<>:: 
10-10-78 24 h 48 h 7 d 37 84~0 63 6 10/8 no active pulm. ----- pleural effusion on day of sur- i 
! 10-12-78 36.8- 3900- 48-85 1-27 disease; 10/12,13, L. gery 
i, 
10-21-78 37.8 16, 400 pleural eff.; 10/14, 16, 48 h post-op atelectasis L.L.L. 
11 18, L.L.L. atel.; 10/20, 
L. pleural eff. & basilar ·• 
atel. changes 
i 
10-ll-78 24 h 48 h 5 d 37 12,1028 60 6 10/9·, 13,14,15,17,19, 10/12 clean catch urine, ---
10-13-78 36.6- 9300- 54-70 1-19 normal chest no growfh in 18 h, 103 • ' 
i 
10-20-78 37.2 15,1400 Lactobacilli in 48 h 
9 I 
10-16-78 384h 96 h 6 d 37 10,1654 69 7 10/16 CHF; 10/20,31, COLD 10/16 spu, normal flora 1 nosocomi.al respiratory infec-
11-1-78 36- 4000- 59-97 1-32 11/1 pulm. edema 11/2,3, 10/20 spu, B streE 2 not A tion, 24 h post-op infiltrate 
11-24-78 38.4 19, 700 RUL infil.; 11/5,6, R. 10/23,30, spu, normal RUL, 4 d post-op pleural ef-
39 pleural eff; 11/9 resolv- flora; 11/3, spu, ~· fusion. ' 
ing; 11/10, 11,13,14,15,17, morganii, Enterobacter 
; 
19,20, L.L.L. infiltrate. aerogenes, E. coli; 
11/10, spu, E. coli, 
P. morganii, 11/11, 
' spu, Enterobacter ~-. genes, E. coli; 11/15, StaEh· eEidermidis, ! 
yeasts, P. morganii; ! 
' 10/20, urine no growth, 
11/9 chest wound, no 
1 growth; 11/11 blood, 
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Table 1. Continued. 
1:'-
C'1 ~ 
~ ~' ... ~ .-< '"' ,., ~"' ... "' ~ >> > ... I ~ ... > I .,;H .,;o "' .,.; ... ... QJ ... 0 "' 0 "' 0 ... CCJ""' .,.,... ....... ....... " oeoo ........ QJ ... QJ ... ... ........ 
"' 0 
0.0 0.0 "' Q) 
QJ 
me::.: c...,; o.,; o.,; 
... "" "" cc.: ~ 0.0 '"' '"' Q) "' Q) "'Q) ....-( t.J· eo I.,.; ....... ._..,.., "''"'"" ... Oil e m e "' ... .,._. Ol .... s Q) c u"' c ., ..... " " c .e.!il 0 c "' > "' ~·~ gj < "'·'"' c..< C..< E-<<"" 
11-2-78 24 h 48 h 13 d 36.6 97~0 
ll-7-78 35.8- a oro-11-22-78 37.2 12 600 
20 
11-4-78 24 h 48 h 8 d 36.6 11l, 650 
11-6-78 36- 63i(o 









11-6-78 24 h 172 h 5 d 37 121.042 11-7-78 36.6- 79~10-
11-15-78 37.4 171,400 11. I 
11-7-78 24 h 72 h 5 d 37.6 73t:O 11-9-78 36.6- 50 oJO-
11-18-78 39.2 96 10 
·11 
I 
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11/5 normal; 11/8 infil. 
R. lung; 11/10,11,12, 
15, R. and L. mid-lung 
infiltrate. 
11/6,7,8, normal; 11/10 
12,14, atel. or infil. 
L. base plus sm. R. 
pleural effusion. . 
11/7,9, clear; 11/10 
atel. L. base; 11/11 
atel. L. & R. lungs; 
11/13 clear. 




.lllJIIi.L ~.1, I!IIIJI,l', 
Post-Operative 
Cultures Complications ' 
11/5 urine, no growth post-op myocardial infarc-
tion 
11/12 spu, B strep, readmitted 12/29 chronic 
not A a,nd Enterobacter • hepatitis,"etiology unknown" 
aerogenes. sputum is considered to be 
colonized. 
11/12 pacer wire site "antibiotic fever? does not 
no growth; 11/9 mitral look sick", infiltrate on 
valve, no growth; 11/12 day of surgery. 
urine no growth; 11/14 
blood no growth. . 
11/10 urine, no growth 3 d post-op atelectasis or 
infiltrate L. base plus small 
R. pleural effusion. 
. 
11/13 blood, no growth; 24 h post-operative atelectasis, 
11/13 urine, no growth; sputum is considered to be 
11/14 sputum, Citrobacter colonized. 
diversus. 
----- Deceased on operative table; 
intraoperative cardiac insuf-
ficiency due to severe coronary . 
arteriosclerosis and pulmonary 
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Table 1. Continued. 
--
00 
"' (';! '"' .. "" .---< OD >. "'"' "'"' '"' "' .. >> >·'"' " .u > .,.;_H .... 0 cr. CJ) .,.; '-' '-' .. 
'-' " ctl'c.J "'" '"' t: Q,)!.;...f "'"'"' ....... ....... " C ellO ... '-' ClJ '-' "''-' '-' .... ... ClJ 0 0.0 0.0 "' .. rr. c;:..= 0...--4 0..--4 o.,.; ... "" a: .:.u 0.0 1.0 1.0 ClJ "' .. 
""'"' u t:.C ,.,.. ........ J..l ~! 0. ... 00 
E o:d ClJ '-' "''-' """ E ClJ d "''~CJ ~!;! ~!;! ~~ ClJ > "' < O...l E-<<<>' 
11-17-78 24 h 24 h 1 d 37 
ll-20-73 36;2-
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'-' 
"" ClJ '-'"' 
'~ d OD ~·, IJ) .. "' ClJ 
~~~ bO So"' to '-' ~~ d ClJ d 





"' .... .---< 
ClJ .. 
UI>O 
"' ClJ """'1>0 d ClJ d 
"' > "' ""<"' 
4 
0-8 
· :tliL:crllll:,!I[J:mmlb:n 1 
Chest X-Rays 
11/17,20, normal; 
ll/21 small infil. L.L.L.; 






11/25 sputum, normal 
flora. 
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Table II 




48 h 3 d 
48 h 5 d 
48 h 10 d 
48 h 6 d 
48 h 5 d 
48 h 4 d 
48 h 1 d 
24 h 5 d 
120 h 9 d 
48 h 5 d 
96 h 5 d 
96 h .. 10 d 
288 h 
48 h 6 d 


















2 nosocomial wound infections 
48 hr. post-op atelectasis 
48 hr. post-op atelectasis 
4 days post-op infiltrative 
changes and CHF 
48 hr. post-op pleural effusion 
and atelectasis 
24 hr. post-op infiltrate or 
atelectasis; 48 hr. pleural effusions 
48 hr. post-op atelectasis 
1 nosocomial wound infection 
5 days post-op pleural effusion 
4 days post-op pleural effusion 
1 nosocomial wound infection 
atelectasis on day of surgery 
7 days post-op basal effusion 
1 nosocomial respiratory infec-
tion;24 hr.~ post-op infiltrate 
1 nosocomial wound infection 
1 nosocomial respiratory infection 
3 days post-op atelectasis 
atelectic changes on day of 
surgery 
1 nosocomial wound infection 












" IVPB Oral 1=7-,, 
Patient Duration Duration Total Complications t 
~ 
16 48 h 5 d 7 atelectasis day of surgery ~ 
n 
'-' 
17 48 h 4 d 6 48 hr.· basal effusion 
It' 
post-op 
18 48 h 9 d 11 24 hr. post-op atelectasis 
72 hr .. post-op pleural fluid 
19 48 h 2 d 4 1 nosocomial wound infection 
l nosocomial urinary fiftection 
20 48 h 7 d 9 pleural effusion on day of surgery 
48 hr.· post-op atelectasis 
21 48 h 5 d 7 
22 96 h 6 d 10 1 nosocomial respiratory infection 
24 hr~ post-op infiltrate 
4 days post-op pleural effusion 




24 48 h 7 d 9 48 hr. pleural fluid 
~ post-op ~ 5 days post-op atelectasis and/or -
infiltrate 
-
25 72 h 3 4 days post-op infiltrate or 
atelectasis 
26 48 h 7 d 9 3 days post-op pleural reaction 
5 days post-op atelectasis 
27 48 h 13 d 15 post-op myocardial infarction 
~ 
~ 
28 48 h 8 d 10 readmitted 12/29 chronic hepatitis; 
~ 
etiology unknown ~ ""' ~
29 48 h 3 d 5 infiltrate on day of surgery 
30 72 h 5 d 8 3 days post-op atelectasis or 
infiltrate 
31 72 h 5 d 8 24 hr. post-op atelectasis 
32 deceased on table, intra-operative 
cardiac insufficiency. 
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Figure I. Frequency Distribution -Days of Post-Operativo 
Prophylactic Antibiotic Therapy 
N = 32 
- 1-y = 7.94 
s = 3t 
Median = 8 
~~· Range = 2 ~ 15 days 
Days of Therapy 
'illf1imll' 1" i' ITII'r :' .:r 1 l.l~rrm:rr:frlli::.lf!fl:l:,:lrlr.: . L:l 1 
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!1"1" : ,!,ll:·c:J;;: :Jl,J:ll:llcib·,, ' l· '" :o: ~:illl.L,"I,li.WJUJ, 
Freq~1ency Distributions - Days of Post-Operative 
Prop+ilactic Antibiotic Therapy for the Infected and 
Non-Infected Groups of Open-Heart Surgery Patients 
Group I :i- No Infection 
Days 
t-.....'-J. t--.... ::;>! • 











Group II - Infection 
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APPENDIX 1 






Rm: 1\IHH·HCROBI!IL SURVEILL/\tlCE RECORD SlfHT 
tlAr~E: __ _-::__ _________________ Wt. -----··--




r~!QT~£~~:~-ll!HBY~- .>TART STOP t!D 
PROPHYLACTIC: Monitored 
Why ~:ound Class__ If Surgery, date __ Day 1 __ _ 
Ratfonale stated?. __ If yes, ~that________________ 2 __ _ 
Agent, dose, and route appropriate? __ If combination, appropriate? 3 __ _ 
4 
!---~T~H~ER~A~P~E~UT~I~C~:~~~~-~--~-~~-~~~~~~E~--NO'-----s-=====~---~ 
Diagnosis of infectious disease documented prior to Rx? 6 
Based on _____ ~-------------- 7 
Appropriate cultures obtained prior to Rx? 8 
9 
::,_P!l.AT!2I.!:.E~NT~OA~Tc~AC!...: --...---.---,- .. _ ---·----.--..---..,...---,--~---.---.1 0 
Pate .. 11 





~at i nine I _.:__..~:___...L __ ___:.. __ _.~ 17 
18 
i;~;:~i-4-·-··_g~gg_· ·_· _· t=l-bl:~ 





---------·-·----------------·------------·-··-~---- --~ ...... -----·-·-·-- ---·~··- ·-··---·~----------··-· -~- .... --.. -------· ···-·--· .. ~-·-· .... 
---~--==--=-~-~-·-------- -------=--..::..:::::...-__ ~-----------
•/ 
COt11~ENTS: (date, summary, and initial) 
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APPENDIX 2 
HOSPITAL PHARMACY ANTIMICROBIAL 
MONITORING REPORT 
,,m 1111ll'lu • ,ji•'lll 
ST. JOSEPH'S HOSPITAL PHAR~·1ACY ANTir~ICROBIAL MONITORING 
REPORT 
.. -. 
DURATION; Sept 1 - Sept. 30 1978 
TOTAL ra.:I1SER OF PATIENTS ~lONITORED 242 * 
I. PROPHYLACTIC THERAPY . NO. % 
A. Total number of patients treated 
s. 
c. 
pro~hylactica11y: 100 l_QQ_% 
1. St:rgical patients 90 90% 
2. Non surgical patients 10 10% 
If Prophy1 acti c: ~priate _g~esti9nable 
l'LQ· % NO_. % 
1. ~~s the rationale 92 92% 8 8 % 
2. Was the dosage 98 9B% -2- -2-% 
3. Has the route 100 100% -:- - % 
4. ~~s the agent selectcdg9 99 % ...L __1.) 
S. If co:r.:Jination of Rx,. """""- - ••. C/ 
~:cs t;~;s _2_ _J'. --- ..:.-!" 
Number of times physician notified: 
1. Reasons: NO. NO. OF CHANGES 
a) Agent selected -L _a_ 
b)~ _2._ _a_ 
c) _____ _ 
d) ---------
2. Percent of patients being treated· 
pro;;hyluctically where a change_ in 
therapy resulted. _o_% 
0. Average Duration of Prophylactic'· . 
therapy. 2.65 days· 
Range 1 dose - 10 days 
II. THERAPEUTIC THERAPY 
A. Tota 1 number of patilents treated 
therapeutically: 
8. If Therapeutic: . YES 




1\0 • <!• 10 
1. Diagnosis of infe~tious 
disease .. l · lJ.L 99. 3% _1_ _,]_ '!. 
to Rx 99. 3;,; .7 % 
2. Diagnosis docum~n·red prior 141 
3. CRultures obtained prior to 122 . 90 % 20 
X -- --
10 % 
4. Cultures appropriate ·11.£. iOO % 
5. Blood cultures obtained 68 .i§_% 
6. Rationale stated 1.!!.._ 99. 3% 
74 
l 





NO. Cf " 
7. ~las the rationale 1 lfl_ 9.2...J.% 
8 •. Has the agent se1 e~cted 138 ·97 % 
9. \·las the dosage I 1 eo 99X 
10. Was the route 142 100 % 
11. If combinations, vrs it ll...lOQ_J~ 





l. Reasons: NO. NO. OF CHNlGES 
a) Dosaae I L _1_ 
b) • P.aent I_ --L ..L 








----" ,,__ -_,, 
d) ·Rational I_ .J_ _o_ 
2. Percent of patient~ being treated therapeutically 
where a change in llher~py resulted. 4.0% 
VJ 
C)1 





:r::1::mJlala"'-'u~ '"lilnllililimlc·J:i ::ub::::~i.tlid.r i·:·· 
-·~---1 
l 
I. :;[J[;:;r:~.[itL·lllrJ::n:n::~:l-1 1 ~~ T Jilllt.L"'IIIIIU~I. 
Pi\GE 2 ST. JOSEPH'S HOSPITAL PHA~'1ACY ANTU1ICROBlAL MONITORING REPORT 
CURATION: Se:;t. 1 - S1ept. 30 1978 . 
.· . I 
TOTAL NU!·lSER OF PATIENTS MONITORED 243 * 
I 
TTT 
"""'·-- DRUG US.t.GE NO. 1 
A. Ce;:;r.a1osporins J.iJ ..QL 
B. Pe.nicii1in Grot;p _n . ...33.. 
c. A~ir.o Glycoside Group _.12 .£9_ 
D. Ch1oramphenico1 5 2· 
E. Misc. I~ ,..UL 
~'i!;is rcjl:-C~r!nts a11 pu.t~·cnts on r+·cntcra1 antimicrohials. I 
\·:i t!l ti~e <!cc!i ti on of ora is for thq~;c patients en Fourth Eust. 
4/78 
IV. SURGICAL HOUND CLASSIFICATION BY S(RVICE- FOR PATi:E~S 
TREATED HITH ANTH1ICROBI.I\LS 
I Ir I I! IV --
A. Ear/Eye/No.se/T.hroat · -=- -=- ~ 
B. General Surgery (G!) 3 12 8 
C. 08/GYN . --:- 16 -:- 1 
D. Orthopedics . ~ _s ,.L _2_ 
E.· Neurology _.J.. .1_ .1_ ......::.. 
F. Urology _3 ..L ..L _ 
G.. Vascular/Thoracic A ..2_ ___ -L 
OHS lQ_ 
' 
I ' ~ • ~ 
~ 
'• 
---------~=----------- -- -- -- -- ---------------------- ------------
APPENDIX 3 
HOSPITAL AMINOGLYCOSIDE MONITORING REPORT 
---- ··--------- ----------- ---·-------
DUfli\TI011 ·------
TOTI\L tiUilflEf( OF PATIWrS 
:IO~IITOEED ----
ST. JOSEPH Is HOS pIT 1\L Pft,~Ri·II\CY 
J\NTIHICROlliJ\L r:OIHTORING 
REPORT 




l. Diagnosis of infec-
ti ous disease - -
2. Diagnosis documented - -prior to Rx 
3. Cultures obtained -prior to Rx 
4. .Cultures appropriate -
5. Blood cultures ob-
titined 
6. RatioMle state 
, 7. Aminoglycoside 
levels 
.8. Creatinine, Bun - -
~riate Questionable 
9. Has the rationale 
10. Has the agent 
selected 
11. Has the dosage 
12. Has the route 
13. If combinations, \'las 
it 
B. Number of times physician contacted: 








2. Pcrcen t of patients being trca ted thc1·apeut i ca lly \·1here a change in therapy 
rcsul ted. _% 
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.I. PfWSPECTIVE JIUDIT CYCLE 
1. Problems Identified: 
2. Recommendations: 
~-------------~-~-~---------------------~--~ 






RETROSPECTIVE EVLAUATON ON THE USE OF 
CEPHALOSPORINS IN OPEN-HEART SURGERY 
~--=­r:--
~~~~~=======~=~-=--==cc========-=---=----=---__c:--=--=--·c_·c.~-- ____ _ ... 
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REl'ROSPW~TIVE EVJI.LU.t\TION ON THE USE OF CE:r-'HALOSPOH.INS IN OPEN-HEART SURGERY 




.. - ·-·------~--- ··-·------ -----~---~··-~----- -~-··--·····--···-·--·-· -~---
-,..-----·-··--·- ··-------------~----·- ··--------·--·---~-· 
1-------------·~--~--r--- ·-----·--·· ---------------· ---·--·--------···-
~-------.·---....-...... ,.w.,_,_ ~ .......... ._..~-----.... ,.. • .__. _ .. _.,._~.-- ....... --.·----------- ____ ...,_..._._ 
I. AntimicrohiaJ. Therau:y for Open-He&rt Surr.:ery 
A. If prouhylact.~.c: appropriate/ouestionable 
1. v!as the r~tionale I 
Criteria: Prophylactic use of antib:i.otics in open hear.t-:-~ur~er. is 3ustified. 
2. \-las the route I 
Criteria: Ancef n.nd Kefiin a.re given intr~venously or-:·intrmnt-ls~ularly-_ ---
and K efl ex orally. 
Criteria: 
'3. Has the nosag:e 
Ancef is usually f;i ven 0. 500 to .1. OOOp:, 
every h-6 hours a.nrl Kefiex 0.250-0.500g 
exceed ~-g in 24 hours, 
every-irh.'Oilr/ Kefl:f.nTg 
every 6 hours, but not to 
4. Hr>s the dur!\tion of prr---rm urophylaxis 
CriteriA.: ?l~ hours Jllaximum; 1.-2 hours minimum. ---'"··-----/ ·----·· 
_5, '.Vas the duratton of nost-op prophylaxis 
Criteria: 48 hours maximum; 2l~ hours minimum. ---/----
B. Complications: Yes / No 
1. Did the ua tient acquire a 
nosocomial infection I 
Criteria: IIInfect:i.ons which exuress themselves in hospitaliz6ci--n-atlents in 
whom the infection was not prP~Pnt or incubatinrt, at the time. of admj.ssion 11 
and 1.nclur1e " infections whi.cl1 A.re potentially preventable as "''~1.1 
as somn that !llay be re~arderl RS inevi.t.1.ble". ref: Center for Di. sease 




? , Jri.d tho nati.Ant. acquire a nosocomial 
t·Tound i.nfect:i.on / 
G:ri. teriB : A surgical Hound rlra:lni.nr: pu:rul ent mater-ial, 't}ie 'c'UIYure~-·· 
may or %'l.ynot b~ positive, 
3. D'i.d the pati(-mt a~quire a nosocomial 
Criteria: 
urinary trnct lnfecti.on . ----·- ----/.. -··--·---·-··--
A colony count on a clean catch or urirw.ry cntheter sample 
AXC!ecding 100,0()0 coionies/Ml. 
4. Jn.rl the patient acquire a nosocomial 
Criteria: 
. :ref;niratorv tract i.nfection I 
Purulent suutu~1, a chest x-ray showinr; infil tr'al'es--~a·f..···othel;--
positive sir;ns, and/or a positive sputum culture~ 
5. Did the p,qtient acquire a nosocomial 
septicemia . / 
Criteria: Presence of bacteria in the blood with clinic-al -sigrfs--ofTnfection. 
Criteria: 
C01-1M~TS: 
6, Did the patient acquire a nosocomial 
infectious endocarrli tis ·---------/-----
Bacteremia, fever, spenomeP.:aly, embolic manisfestations, new 
heart murmer, _or a positive cu.lture from the valve or heart. Infectious 
bacterial endo,::ardi tis is diagnosed if the pati·ent demonstrates three 









C. Patient Data 
-----t---1·--····---
.__ __ ..._ ___ .. _ .-~...,- - ----..J.._ ..... ___ _ 
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